<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>9 patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) were treated with bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="1" pm="."><plain>5 were conditioned with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and received and HLA-identical graft (4 patients) or a mismatched graft (1 patient): 1 rejected the graft on day 30 and died on day 34 during conditioning for a second transplant; 1 died on day 15 with <z:hpo ids='HP_0011009'>acute</z:hpo> and severe <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> (GvHD) in the absence of haemopoietic engraftment; 3 are alive and complete chimeras at 1,069, 490 and 332 days after transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>GvHD developed in 4 patients and was treated successfully in 3 with high dose <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> and/or antilymphocytic globulin (ALG) </plain></SENT>
<SENT sid="3" pm="."><plain>4 patients were conditioned with ALG and received bone marrow from a haploidentical sibling or parent: 1 patient was refractory; 3 patients showed evidence of hematologic reconstitution, but 2 of these required a second course of ALG </plain></SENT>
<SENT sid="4" pm="."><plain>3 patients in this group are alive between 60 and 490 days; 1 patient died on day 121 of HBSAg-negative <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> </plain></SENT>
</text></document>